by danka | Jun 17, 2025 | Speakers Biosimilars LatAm - Brazil 2025
U.S. FDA/CDER/OND/OTBB, United States Director Scientific Review Staff Since joining FDA in 2005, Dr. Ricci’s career has focused on the review of biotechnology-derived therapeutic proteins where she has made major contributions to policy, guidance and scientific...
by danka | Jun 17, 2025 | Speakers Biosimilars LatAm - Brazil 2025
Amgen, Brazil Sr. Manager, Global Safety – Pharmacovigilance lead for Brazil Hub Silvia Giaffone is Senior Manager and Pharmacovigilance Lead for the Brazil and Argentina affiliates at Amgen. With over 17 years of experience in regulatory affairs and 9 years in...
by danka | Jun 17, 2025 | Uncategorized
Sandoz, Brazil Portfolio & Launches Director Geisa Cavalari is a Pharmaceutical-Biochemist with over 18 years of experience in Regulatory Affairs and project management in the pharmaceutical industry. She currently leads portfolio and product launches at Sandoz...
by danka | Jun 11, 2025 | Speakers Biosimilars LatAm - Brazil 2025
Tecnológico de Monterrey, Mexico Associate Professor Biotechnological engineer, Master in Biochemical Science, Specialist in Pharmacology and Applied Statistics, and Ph.D. in Experimental Clinical Research (Clinical Pharmacology, Pharmacokinetics and...
by danka | Apr 8, 2025 | Speakers Biosimilars LatAm - Colombia 2025, Uncategorized
Verseds, Colombia Chief Executive Officer Vladimir Camacho Cuineme is an accomplished financial executive with over 15 years of international experience in risk management, financial control, auditing, and strategic planning. As Director of Financial Risk and Audit at...
